Drug General Information (ID: DDIURBSKL1)
  Drug Name Nitroprusside Drug Info Iodide I-123 Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antihypertensive Agents Diagnostic Radiopharmaceuticals
  Structure

 Mechanism of Nitroprusside-Iodide I-123 Interaction (Severity Level: Moderate)
     Interference of cell/tissue uptake Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Nitroprusside Iodide I-123
      Mechanism Interfere with the therapeutic effect and/or diagnostic result of radioiodides Radioiodide
      Key Mechanism Factor 1
Factor Name Pharmacokinetics
Factor Description Alters the distribution of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects.
      Mechanism Description
  • Interference of cell/tissue uptake of Iodide I-123 by Nitroprusside 

Recommended Action
      Management Antithyroid agents such as carbimazole or propylthiouracil should generally be withheld for 1 week before administration of sodium iodide I-131 or I-123, and for a few days afterward. Salicylates, steroids, anticoagulants, antihistamines, antiparasitics, penicillins, sulfonamides, tolbutamide, thiopental, and nitroprusside should generally be withheld for 1 week. Amiodarone, lithium, and benzodiazepines should be withheld for at least 4 weeks.

References
1 Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
2 Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
3 Product Information. Sodium Iodide I-123 (sodium iodide I-123). GE Healthcare, Princeton, NJ.